Boothbay Fund Management »

Aeglea Biotherapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.0M 86k 23.28
2024-09-30 $2.7M 92k 29.41